Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1-step vs 2-step Injectable Artesunate for Severe Malaria
NCT05140278Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jul 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artesunate in malaria, sponsored by University of Oxford. Started Jul 2022; status: completed.
02
Drugs
artesunate
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05140278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05140278.